Latest Dilution News

Chimeric Therapeutics has secured a $2.5 million advance against its FY25 R&D tax incentive, bolstering funding for its clinical trial pipeline and operational needs. This move complements recent capital raises and underscores the company’s strategic financial management amid its oncology-focused cell therapy development.

Macquarie Group Limited has updated its final dividend details, confirming a fully franked AUD 3.90 per share payout and setting the Dividend Reinvestment Plan price at AUD 213.66 based on recent trading averages.

Alara Resources has announced a private placement to raise A$3.4 million aimed at repaying a significant portion of its Trafigura loan, subject to shareholder approval. The move underscores strong backing from major shareholders and a strategic focus on financial stability.

Aguia Resources has locked in $750,000 through convertible notes to bolster working capital, pending shareholder approval expected in mid-July. The notes carry a 10% interest rate and come with free options, signaling cautious optimism about the company’s near-term funding needs.

Careteq Limited has raised $625,000 through a convertible note from investor Antanas Guoga and loans from its board, strengthening its working capital position for the medium term.

S2 Resources has raised A$3.5 million through a placement and share purchase plan to fund exploration across multiple Australian gold and base metal projects. The capital injection aims to maintain momentum while balancing shareholder interests.

Botanix Pharmaceuticals has secured a US$30 million debt facility from Kreos Capital, bolstering its financial position to commercialize Sofdra™ and pursue platform expansion opportunities.

Prodigy Gold NL has announced a non-renounceable entitlement offer aiming to raise approximately $6.35 million to fund exploration and development across its key gold projects in the Tanami region. The offer is partially underwritten, providing a degree of funding certainty amid ongoing market and operational risks.

Caravel Minerals has locked in a $15 million loan facility to fund the critical Definitive Feasibility Study for its flagship Caravel Copper Project, advancing the path to development without diluting shareholder equity.

Genesis Minerals has strategically acquired Focus Minerals' Laverton Gold Project, adding approximately 4 million ounces of gold resources near its existing Laverton mill. This fully funded $250 million bolt-on deal significantly enhances Genesis’ resource base and production outlook.

Emmerson Resources reveals a promising update on its White Devil gold project, confirming a major mine development opportunity with over 60% of its 611,400oz resource convertible to an open pit. The Scoping Study is on track for completion by early July 2025, setting the stage for a Pre-Feasibility Study.

Prodigy Gold NL has launched a partially underwritten entitlement offer to raise up to $6.35 million, aiming to accelerate exploration and development across its key Tanami gold projects. Major shareholders APAC Resources and Plutus Prospecting are backing the raise, with potential board changes on the horizon.